Anuh Pharma enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025
798——
52.952.973.4
0.00.010.5
745——
−52.9−52.9−62.9
₹74.33——
352352337
0.0%0.0%3.1%
0.96×——
11.49×——
13.91×——
Reference items — trailing FY values
779772662
64.961.760.9
53.650.352.2
—−3.037.1
−10.9−10.917.2
—−11.017.1
—7.920.0
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

ANUHPHR₹79.61

Anuh Pharma Limited

· Pharma & Health
₹ CrorePeersAHCLWANBURYZIMLABBAJAJHCARETHEMISMEDLINCOLNVALIANTLABSIGACHIMcap ₹798 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization——797.9
- Cash, Equiv & ST Investments73.452.952.9
+ Total Debt10.50.00.0
Enterprise Value——745.0
Net Debt (memo)-62.9-52.9-52.9
EV per Share——74.33
Total Capital336.5352.2352.2
Total Debt/Total Capital3.120.000.00
EV/Sales——0.96
EV/EBITDA——11.49
EV/EBIT——13.91
Reference Items — Trailing FY Values
Sales661.5771.7779.0
EBITDA60.961.764.9
EBIT52.250.353.6
Operating Cash Flow37.1-3.0—
Free Cash Flow17.2-10.9-10.9
FCFF (free cash flow to the firm)17.1-11.0—
Capital Expenditure20.07.9—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.